KDx Diagnostics Inc. announces issuance of patents covering URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States and Europe

Posted on by

SAN JOSE, Calif., Oct. 5, 2023 /PRNewswire/ — KDx Diagnostics Inc., a leading innovator in non-invasive bladder cancer tests, is pleased to announce the issuance of important patents in the US, EU, and South Korea relating to their joint work in developing new tests to aid in the…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.